These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 27294139)
1. Deposition of BACE-1 Protein in the Brains of APP/PS1 Double Transgenic Mice. Luo G; Xu H; Huang Y; Mo D; Song L; Jia B; Wang B; Jin Z; Miao Z Biomed Res Int; 2016; 2016():8380618. PubMed ID: 27294139 [TBL] [Abstract][Full Text] [Related]
2. Neuronal and glial beta-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology. Rossner S; Apelt J; Schliebs R; Perez-Polo JR; Bigl V J Neurosci Res; 2001 Jun; 64(5):437-46. PubMed ID: 11391698 [TBL] [Abstract][Full Text] [Related]
3. miR-124 downregulates BACE 1 and alters autophagy in APP/PS1 transgenic mice. Du X; Huo X; Yang Y; Hu Z; Botchway BOA; Jiang Y; Fang M Toxicol Lett; 2017 Oct; 280():195-205. PubMed ID: 28867212 [TBL] [Abstract][Full Text] [Related]
5. Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease. Paris D; Ganey NJ; Laporte V; Patel NS; Beaulieu-Abdelahad D; Bachmeier C; March A; Ait-Ghezala G; Mullan MJ J Neuroinflammation; 2010 Mar; 7():17. PubMed ID: 20211007 [TBL] [Abstract][Full Text] [Related]
6. Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease. Liang B; Duan BY; Zhou XP; Gong JX; Luo ZG J Biol Chem; 2010 Sep; 285(36):27737-44. PubMed ID: 20595388 [TBL] [Abstract][Full Text] [Related]
7. Icariin decreases the expression of APP and BACE-1 and reduces the β-amyloid burden in an APP transgenic mouse model of Alzheimer's disease. Zhang L; Shen C; Chu J; Zhang R; Li Y; Li L Int J Biol Sci; 2014; 10(2):181-91. PubMed ID: 24550686 [TBL] [Abstract][Full Text] [Related]
8. Folic acid deficiency enhances abeta accumulation in APP/PS1 mice brain and decreases amyloid-associated miRNAs expression. Liu H; Tian T; Qin S; Li W; Zhang X; Wang X; Gao Y; Huang G J Nutr Biochem; 2015 Dec; 26(12):1502-8. PubMed ID: 26345540 [TBL] [Abstract][Full Text] [Related]
9. Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. Dewachter I; Reversé D; Caluwaerts N; Ris L; Kuipéri C; Van den Haute C; Spittaels K; Umans L; Serneels L; Thiry E; Moechars D; Mercken M; Godaux E; Van Leuven F J Neurosci; 2002 May; 22(9):3445-53. PubMed ID: 11978821 [TBL] [Abstract][Full Text] [Related]
10. Multitarget Therapeutic Effect of Fasudil in APP/PS1transgenic Mice. Yu JZ; Li YH; Liu CY; Wang Q; Gu QF; Wang HQ; Zhang GX; Xiao BG; Ma CG CNS Neurol Disord Drug Targets; 2017; 16(2):199-209. PubMed ID: 27401064 [TBL] [Abstract][Full Text] [Related]
11. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients. Li R; Lindholm K; Yang LB; Yue X; Citron M; Yan R; Beach T; Sue L; Sabbagh M; Cai H; Wong P; Price D; Shen Y Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3632-7. PubMed ID: 14978286 [TBL] [Abstract][Full Text] [Related]
12. Fenofibrate reduces amyloidogenic processing of APP in APP/PS1 transgenic mice via PPAR-α/PI3-K pathway. Zhang H; Gao Y; Qiao PF; Zhao FL; Yan Y Int J Dev Neurosci; 2014 Nov; 38():223-31. PubMed ID: 25447788 [TBL] [Abstract][Full Text] [Related]
13. Lack of human-like extracellular sortilin neuropathology in transgenic Alzheimer's disease model mice and macaques. Zhou FQ; Jiang J; Griffith CM; Patrylo PR; Cai H; Chu Y; Yan XX Alzheimers Res Ther; 2018 Apr; 10(1):40. PubMed ID: 29690919 [TBL] [Abstract][Full Text] [Related]
14. Age-dependent differential expression of BACE splice variants in brain regions of tg2576 mice. Zohar O; Pick CG; Cavallaro S; Chapman J; Katzav A; Milman A; Alkon DL Neurobiol Aging; 2005; 26(8):1167-75. PubMed ID: 15917100 [TBL] [Abstract][Full Text] [Related]
15. High-fat diet induced discrepant peripheral and central nervous systems insulin resistance in APPswe/PS1dE9 and wild-type C57BL/6J mice. Guo Y; Ma X; Li P; Dong S; Huang X; Ren X; Yuan L Aging (Albany NY); 2020 Dec; 13(1):1236-1250. PubMed ID: 33291072 [No Abstract] [Full Text] [Related]
16. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease. Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037 [TBL] [Abstract][Full Text] [Related]
17. Treadmill exercise decreases β-amyloid burden in APP/PS1 transgenic mice involving regulation of the unfolded protein response. Xia J; Li B; Yin L; Zhao N; Yan Q; Xu B Neurosci Lett; 2019 Jun; 703():125-131. PubMed ID: 30905823 [TBL] [Abstract][Full Text] [Related]
18. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease. Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117 [TBL] [Abstract][Full Text] [Related]
19. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo. Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133 [TBL] [Abstract][Full Text] [Related]
20. Distribution and expression of Pen-2 in the central nervous system of APP/PS1 double transgenic mice. Chu Y; Peng X; Long Z; Wang K; Luo S; Sharma A; He G Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):258-66. PubMed ID: 25736404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]